Calvert Small-Cap Fund Class A (CCVAX) Fund Overview

Calvert Small-Cap Fund Class A (CCVAX) Financial Services Profile

Calvert Small-Cap Fund Class A (CCVAX) is an asset management vehicle dedicated to long-term capital appreciation through strategic allocation to U.S. small-capitalization equities. The fund targets companies with market valuations akin to the Russell 2000® Index, maintaining at least 80% exposure to this segment while offering diversification with up to 25% non-U.S. securities.

What Is the Investment Thesis for CCVAX?

Calvert Small-Cap Fund Class A (CCVAX) presents an investment vehicle structured for long-term capital appreciation through focused exposure to the U.S. small-capitalization market. With a market capitalization of $1.43 billion and a Beta of 1.01, the fund's performance is closely aligned with the broader market, particularly the small-cap segment. A primary value driver is its commitment to allocating at least 80% of its net assets to small-company stocks, defined by market valuations comparable to the Russell 2000® Index, offering investors direct access to this growth-oriented sector. The fund's diversification across numerous small-cap holdings is a key strength, aiming to mitigate idiosyncratic risks associated with individual smaller companies. Growth catalysts include potential periods of strong economic expansion that typically benefit small businesses, leading to increased earnings and valuations within the fund's portfolio. The flexibility to invest up to 25% in non-U.S. securities also provides an avenue for additional diversification and potential growth from international small-cap markets. However, investors must consider the inherent volatility of the small-cap market, which can lead to greater price fluctuations compared to large-cap funds. Monitoring the fund's tracking error relative to its benchmark and the overall economic outlook for small businesses remains crucial for assessing its performance.

Based on FMP financials and quantitative analysis

CCVAX Key Highlights

Manages $1.43 billion in assets, indicating significant investor interest and scale within the small-cap fund category.

• Maintains a Beta of 1.01, suggesting its price movements are closely correlated with the overall market, particularly the small-cap segment.
• Commits at least 80% of its total net assets to common shares of smaller U.S. businesses, aligning with its core investment mandate.
• Defines 'small companies' by market valuations comparable to the Russell 2000® Index, providing a clear and consistent investment universe.
• Offers no dividend yield, reflecting its primary objective of long-term capital appreciation rather than income generation.

Who Are CCVAX's Competitors?

CCVAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CCVAX's Key Strengths?

Clear investment mandate with at least 80% allocation to U.S. small-cap companies, providing focused exposure.

• Diversification across numerous small-cap holdings, mitigating individual company risk.
• Flexibility to invest up to 25% in non-U.S. securities, offering potential for broader growth opportunities and diversification.
• Aims for long-term capital appreciation, aligning with growth-oriented investor objectives.

What Are CCVAX's Weaknesses?

Inherent volatility of the small-cap market can lead to greater price fluctuations compared to large-cap funds.

• No dividend yield, which may not appeal to income-focused investors.
• Potential for tracking error relative to its benchmark index, requiring careful monitoring.
• Performance is closely tied to the overall small-cap market segment, limiting independent outperformance during broad downturns.

What Are the Key Risks for CCVAX?

Inherent volatility of the small-cap market, which can result in significant price fluctuations and potentially higher drawdowns compared to large-cap investments.

• Economic downturns or recessions, which tend to disproportionately affect smaller businesses due to their more limited resources and market reach.
• Tracking error relative to the Russell 2000® Index, where the fund's performance may deviate from its stated benchmark due to investment selection or market factors.
• Regulatory changes within the financial services sector or specific to mutual funds that could increase compliance costs or alter investment flexibility.
• Increased competition from other small-cap funds, potentially leading to fee pressures or a dilution of market share for Calvert Small-Cap Fund Class A.

What Threats Does CCVAX Face?

• Economic downturns or recessions can disproportionately impact small businesses, leading to underperformance.
• Increased competition from other small-cap mutual funds and ETFs, potentially pressuring fees and market share.
• Adverse regulatory changes impacting mutual funds or the broader financial services industry.
• Sustained periods of underperformance relative to its benchmark or peer group could lead to investor outflows.

What Are CCVAX's Competitive Advantages?

• **Diversification:** Offers a diversified portfolio of small-cap companies, reducing single-stock risk for investors.
• **Defined Investment Mandate:** A clear strategy of investing at least 80% in small U.S. companies, benchmarked to the Russell 2000® Index, provides transparency and focus.
• **Brand Reputation:** As part of Calvert, a known entity in asset management, the fund benefits from established trust and investor recognition.
• **Access to Expertise:** Leverages the investment research and management capabilities of its parent organization to identify and select small-cap opportunities.

What Does CCVAX Do?

The Calvert Small-Cap Fund Class A (CCVAX) operates within the asset management industry, specifically targeting the small-capitalization segment of the equity market. Its core objective is to deliver significant long-term growth for investors by strategically allocating capital to the common shares of smaller U.S. businesses. The fund's investment strategy is clearly defined: at least 80% of its total net assets, which includes any borrowed capital utilized for investment purposes, are dedicated to these small-company stocks. This commitment ensures a focused exposure to the growth potential inherent in smaller enterprises. The fund's management employs a specific criterion for defining "small companies," considering those with market valuations comparable to the constituents of the Russell 2000® Index at the time of investment. This benchmark provides a consistent framework for identifying suitable investment opportunities within the small-cap universe. While primarily focused on domestic small-caps, the fund maintains a degree of flexibility, allowing it to invest up to a maximum of 25% of its net assets in non-U.S. securities. This provision enables the fund to potentially capture growth opportunities outside the U.S. market or enhance diversification, depending on market conditions and the fund manager's assessment. As a mutual fund, CCVAX provides investors with a diversified portfolio of small-cap holdings, aiming to mitigate individual stock risk while participating in the broader small-cap market's performance. The fund's approach combines a clear mandate for long-term growth with a defined investment universe, positioning it as a vehicle for investors seeking exposure to this dynamic market segment.

What Products and Services Does CCVAX Offer?

• Invests primarily in common shares of smaller U.S. businesses.
• Seeks to deliver significant long-term growth for investors.
• Allocates at least 80% of its total net assets to small-company stocks.
• Defines 'small companies' as those with market valuations comparable to the Russell 2000® Index at the time of investment.
• Has the flexibility to invest up to 25% of its net assets in non-U.S. securities.
• Provides investors with diversified exposure to the small-capitalization equity market.
• Operates as a mutual fund, pooling investor capital for collective investment.

How Does CCVAX Make Money?

• Generates revenue through management fees charged as a percentage of assets under management (AUM).
• Incurs operating expenses, including administrative, marketing, and distribution costs, which are typically passed on to investors through an expense ratio.
• Aims to increase its net asset value (NAV) per share through capital appreciation of its underlying investments.
• Attracts and retains investor capital by delivering competitive long-term returns relative to its investment objective and benchmark.

What Industry Does CCVAX Operate In?

Calvert Small-Cap Fund Class A operates within the highly competitive asset management industry, specifically targeting the small-capitalization equity segment. This industry is characterized by a diverse range of investment products, including mutual funds, exchange-traded funds (ETFs), and separately managed accounts, all vying for investor capital. The small-cap market segment itself is known for its higher growth potential and increased volatility compared to large-cap markets, often attracting investors seeking aggressive growth opportunities. CCVAX positions itself as a dedicated vehicle for accessing this segment, with its strategy of investing at least 80% of its net assets in small U.S. companies. The competitive landscape includes numerous other small-cap funds offered by major financial institutions, each with varying investment philosophies, expense ratios, and management styles. CCVAX's adherence to the Russell 2000® Index as a benchmark for defining small companies places it directly in competition with funds that track or aim to outperform this widely recognized small-cap index, necessitating consistent performance and clear communication of its investment approach to attract and retain investors.

Who Are CCVAX's Key Customers?

• Individual investors seeking long-term capital growth.
• Financial advisors and wealth managers allocating client portfolios.
• Institutional investors looking for diversified small-cap equity exposure.
• Investors comfortable with the higher volatility associated with small-capitalization stocks.

CCVAX Financials

CCVAX Latest News

No recent news available for CCVAX.

CCVAX Analyst Consensus

CCVAX MoonshotScore

Calvert Small-Cap Fund Class A Financials Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources